Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (34)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Almog, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Almog, Y.
(Chest. 2003;124:740-743.)
© 2003 American College of Chest Physicians

Statins, Inflammation, and Sepsis*

Hypothesis

Yaniv Almog, MD

* From the Medical Intensive Care Unit, Soroka University Medical Center, Faculty of Health Sciences, Ben-Gurion University, Beer-Sheva, Israel.

Correspondence to: Yaniv Almog, MD, Medical Intensive Care Unit, Soroka University Medical Center, PO Box 151, Beer-Sheva, 84101 Israel; e-mail: almogya{at}bgumail.bgu.ac.il

Sepsis and septic shock are complex inflammatory syndromes. Multiple cellular activation processes are involved, and many humoral cascades are triggered. Statins have anti-inflammatory properties. Our preliminary observations indicate that patients receiving therapy with statins may have a lower incidence of severe sepsis. We hypothesize that statins have a strong protective effect against sepsis by virtue of diverse anti-inflammatory effects that are independent of their lipid-lowering ability.

Key Words: anti-inflammatory • apoptosis • nitric oxide • sepsis • statins




This article has been cited by other articles:


Home page
ThoraxHome page
E M W van de Garde, E Hak, P C Souverein, A W Hoes, J M M van den Bosch, and H G M Leufkens
Statin treatment and reduced risk of pneumonia in patients with diabetes
Thorax, November 1, 2006; 61(11): 957 - 961.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. Arnaud, F. Burger, S. Steffens, N. R. Veillard, T. H. Nguyen, D. Trono, and F. Mach
Statins Reduce Interleukin-6-Induced C-Reactive Protein in Human Hepatocytes: New Evidence for Direct Antiinflammatory Effects of Statins
Arterioscler. Thromb. Vasc. Biol., June 1, 2005; 25(6): 1231 - 1236.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. B. Fessler, S. K. Young, S. Jeyaseelan, J. G. Lieber, P. G. Arndt, J. A. Nick, and G. S. Worthen
A Role for Hydroxy-Methylglutaryl Coenzyme A Reductase in Pulmonary Inflammation and Host Defense
Am. J. Respir. Crit. Care Med., March 15, 2005; 171(6): 606 - 615.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. L. Stoll, G. M. Denning, and N. L. Weintraub
Potential Role of Endotoxin as a Proinflammatory Mediator of Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., December 1, 2004; 24(12): 2227 - 2236.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y. Almog, A. Shefer, V. Novack, N. Maimon, L. Barski, M. Eizinger, M. Friger, L. Zeller, and A. Danon
Prior Statin Therapy Is Associated With a Decreased Rate of Severe Sepsis
Circulation, August 17, 2004; 110(7): 880 - 885.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
K.-i. Inoue, H. Takano, R. Yanagisawa, M. Sakurai, T. Yoshikawa, and Y. Almog
Statin, Inflammation, and Sepsis
Chest, June 1, 2004; 125(6): 2365 - 2365.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American College of Chest Physicians.